US5629020A
(en)
*
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US5578323A
(en)
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US6331318B1
(en)
*
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5443841A
(en)
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US5693338A
(en)
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US6099856A
(en)
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5352461A
(en)
*
|
1992-03-11 |
1994-10-04 |
Pharmaceutical Discovery Corporation |
Self assembling diketopiperazine drug delivery system
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US6916489B2
(en)
*
|
1992-06-15 |
2005-07-12 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5811127A
(en)
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5401516A
(en)
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
AU6819294A
(en)
|
1993-04-22 |
1994-11-08 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US20010003001A1
(en)
|
1993-04-22 |
2001-06-07 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6461643B2
(en)
|
1993-04-22 |
2002-10-08 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5958457A
(en)
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5643957A
(en)
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5709861A
(en)
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US5466259A
(en)
*
|
1994-03-07 |
1995-11-14 |
Durette; Jean-Francois |
Orbital implant and method
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6524557B1
(en)
*
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
NZ298169A
(en)
|
1994-12-22 |
1999-09-29 |
Astra Ab |
Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
|
CN1151836C
(zh)
|
1995-03-31 |
2004-06-02 |
艾米斯菲尔技术有限公司 |
用作传送活性剂的化合物和组合物
|
US6090958A
(en)
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5989539A
(en)
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
US5965121A
(en)
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5820881A
(en)
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US6428771B1
(en)
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US6051258A
(en)
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
US5824345A
(en)
*
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
US5667806A
(en)
|
1995-06-07 |
1997-09-16 |
Emisphere Technologies, Inc. |
Spray drying method and apparatus
|
WO1997010197A1
(en)
|
1995-09-11 |
1997-03-20 |
Emisphere Technologies, Inc. |
METHOD FOR PREPARING φ-AMINOALKANOIC ACID DERIVATIVES FROM CYCLOALKANONES
|
JP2000500461A
(ja)
*
|
1995-11-13 |
2000-01-18 |
スミスクライン・ビーチャム・コーポレイション |
血液調節化合物
|
SI9720025A
(sl)
|
1996-03-29 |
1999-08-31 |
Emishphere Technologies, Inc. |
Spojine in sestavki za prenos aktivne snovi
|
EP0904065A4
(en)
|
1996-06-14 |
2000-06-14 |
Emisphere Tech Inc |
MICRO-ENCLOSED FRAGRANCES AND PRODUCTION METHOD
|
CA2243643A1
(en)
|
1996-11-18 |
1998-05-28 |
Susan Haas |
Methods and compositions for inducing oral tolerance in mammals
|
US5876710A
(en)
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US5804688A
(en)
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5879681A
(en)
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
US5990166A
(en)
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US6060513A
(en)
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5939381A
(en)
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5863944A
(en)
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
US5891237A
(en)
*
|
1997-10-08 |
1999-04-06 |
Millennium Inorganic Chemicals, Ltd. |
Production of free flowing spheres using partially neutralized fatty acid
|
ES2242412T3
(es)
|
1998-07-27 |
2005-11-01 |
Emisphere Technologies, Inc. |
Compuestos que permiten administrar agentes activos y composiciones a base de estos compuestos.
|
US6440929B1
(en)
|
1998-07-27 |
2002-08-27 |
Emisphere Technologies, Inc. |
Pulmonary delivery of active agents
|
WO2000007979A2
(en)
*
|
1998-08-07 |
2000-02-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6991798B1
(en)
|
1998-08-07 |
2006-01-31 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
WO2000040203A2
(en)
|
1999-01-08 |
2000-07-13 |
Emisphere Technologies, Inc. |
Polymeric delivery agents and delivery agent compounds
|
WO2000050050A1
(en)
*
|
1999-02-23 |
2000-08-31 |
Isis Pharmaceuticals, Inc. |
Multiparticulate formulation
|
AU3378100A
(en)
|
1999-02-26 |
2000-09-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
ES2235854T3
(es)
*
|
1999-04-05 |
2005-07-16 |
Emisphere Technologies, Inc. |
Sales disodicas, monohidratos y solvatos etanolicos para aportar agentes activos.
|
EP1196430B1
(en)
*
|
1999-06-29 |
2012-02-15 |
MannKind Corporation |
Purification and stabilization of peptide and protein pharmaceutical agents
|
AU2012201760B2
(en)
*
|
1999-06-29 |
2015-04-16 |
Mannkind Corporation |
Purification and stabilization of peptide and protein pharmaceutical agents
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US7279597B1
(en)
|
1999-11-05 |
2007-10-09 |
Emisphere Technologies, Inc. |
Phenyl amine carboxylic acid compounds and compositions for delivering active agents
|
US7129274B1
(en)
|
1999-11-05 |
2006-10-31 |
Emisphere Technologies Inc. |
Phenoxy carboxylic acid compounds and compositions for delivering active agents
|
CA2391660C
(en)
|
1999-11-15 |
2009-11-24 |
Biocure, Inc. |
Responsive polymeric hollow particles
|
WO2001044199A1
(en)
|
1999-12-16 |
2001-06-21 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US7833549B2
(en)
*
|
2000-01-19 |
2010-11-16 |
Mannkind Corporation |
Dry powder formulations of antihistamine for nasal administration
|
US6808707B2
(en)
*
|
2000-02-04 |
2004-10-26 |
Matrix Design |
Wound healing compositions and methods using tropoelastin and lysyl oxidase
|
DE10019879A1
(de)
*
|
2000-04-20 |
2001-10-25 |
Degussa |
Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
|
US6537968B1
(en)
*
|
2000-07-24 |
2003-03-25 |
Alphamed Pharmaceuticals Corp |
Treatment of lupus erythematosus
|
CA2774959C
(en)
|
2000-08-04 |
2016-05-31 |
Dmi Biosciences, Inc. |
Method of using diketopiperazines and composition containing them
|
WO2002062797A2
(en)
*
|
2000-12-29 |
2002-08-15 |
Celltech R & D, Inc. |
Pharmaceutical uses and synthesis of diketopiperazines
|
US20030225300A1
(en)
*
|
2001-04-19 |
2003-12-04 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
AU2003205226A1
(en)
*
|
2002-01-18 |
2003-09-02 |
Mannkind Corporation |
Compositions for treatment or prevention of bioterrorism
|
ES2425392T3
(es)
|
2002-03-20 |
2013-10-15 |
Mannkind Corporation |
Cartucho para un aparato de inhalación
|
US7053034B2
(en)
*
|
2002-04-10 |
2006-05-30 |
Salvona, Llc |
Targeted controlled delivery compositions activated by changes in pH or salt concentration
|
US20050238724A1
(en)
*
|
2002-04-23 |
2005-10-27 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical composition containing lamotrigine particles of defined morphology
|
AU2003231777C1
(en)
*
|
2002-04-29 |
2009-10-29 |
Supernus Pharmaceuticals, Inc. |
Pharmaceutical formulations with improved bioavailability
|
US20040038865A1
(en)
*
|
2002-08-01 |
2004-02-26 |
Mannkind Corporation |
Cell transport compositions and uses thereof
|
CA2493478C
(en)
*
|
2002-08-01 |
2014-11-18 |
Mannkind Corporation |
Cell transport compositions and uses thereof
|
US20080260838A1
(en)
*
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
US20040171518A1
(en)
*
|
2003-02-27 |
2004-09-02 |
Medtronic Minimed, Inc. |
Compounds for protein stabilization and methods for their use
|
US20040224024A1
(en)
*
|
2003-04-23 |
2004-11-11 |
Massachusetts Institute Of Technology |
Controlled drug release formulations containing polyion complexes
|
JP2007500747A
(ja)
|
2003-05-15 |
2007-01-18 |
ディーエムアイ バイオサイエンシズ インコーポレイテッド |
T細胞媒介性疾患の処置
|
CA2533128A1
(en)
*
|
2003-07-31 |
2005-02-10 |
3M Innovative Properties Company |
Bioactive compositions comprising triazines
|
US8921311B2
(en)
|
2003-08-01 |
2014-12-30 |
Mannkind Corporation |
Method for treating hyperglycemia
|
WO2005080983A2
(en)
*
|
2003-09-23 |
2005-09-01 |
Wisconsin Alumni Research Foundation |
Using liquid crystals to detect affinity microcontact printed biomolecules
|
US7795007B2
(en)
|
2003-09-23 |
2010-09-14 |
Wisconsin Alumni Research Foundation |
Detection of post-translationally modified peptides with liquid crystals
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
NZ548980A
(en)
*
|
2004-01-12 |
2009-10-30 |
Mannkind Corp |
Reducing serum proinsulin levels in type 2 diabetics
|
US20070027063A1
(en)
*
|
2004-01-12 |
2007-02-01 |
Mannkind Corporation |
Method of preserving the function of insulin-producing cells
|
JP2005209106A
(ja)
*
|
2004-01-26 |
2005-08-04 |
Nec Corp |
携帯通信端末、受信メール管理方法、プログラムおよび記録媒体
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
PL1740154T3
(pl)
*
|
2004-03-12 |
2009-11-30 |
Biodel Inc |
Kompozycje insuliny o ulepszonym wchłanianiu
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
ATE486064T1
(de)
|
2004-08-20 |
2010-11-15 |
Mannkind Corp |
Katalyse der diketopiperazinsynthese
|
PL1791542T3
(pl)
*
|
2004-08-23 |
2015-11-30 |
Mannkind Corp |
Sole diketopiperazyny do dostarczania leków
|
JP2008510825A
(ja)
*
|
2004-08-23 |
2008-04-10 |
マンカインド コーポレイション |
ホスホジエステラーゼ5型の阻害剤の肺送達
|
EP1858486A2
(en)
*
|
2005-01-10 |
2007-11-28 |
MannKind Corporation |
Methods and compositions for minimizing accrual of inhalable insulin in the lungs
|
EP2476756A1
(en)
|
2005-06-15 |
2012-07-18 |
Massachusetts Institute of Technology |
Amine-containing lipids and uses thereof
|
US20070128685A1
(en)
*
|
2005-07-01 |
2007-06-07 |
Rodolfo Faudoa |
Methods and compositions for cell culture
|
US20070003541A1
(en)
*
|
2005-07-01 |
2007-01-04 |
Rodolfo Faudoa |
Methods and compositions for therapeutics
|
US20070004036A1
(en)
*
|
2005-07-01 |
2007-01-04 |
Rodolfo Faudoa |
Methods and compositions for keratinocyte culture
|
AU2006290870B2
(en)
|
2005-09-14 |
2013-02-28 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
ATE443658T1
(de)
*
|
2005-11-21 |
2009-10-15 |
Mannkind Corp |
Pulverabgabe und -erfassungsvorrichtung und - verfahren
|
EP2497484A3
(en)
|
2006-02-22 |
2012-11-07 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
MX2008013165A
(es)
|
2006-04-12 |
2009-01-29 |
Biodel Inc |
Formulaciones de combinacion de insulina de accion rapida y accion larga.
|
KR101438839B1
(ko)
*
|
2006-04-14 |
2014-10-02 |
맨카인드 코포레이션 |
글루카곤 유사 펩타이드 1 (glp-1) 약제학적 제제
|
BRPI0714616A2
(pt)
*
|
2006-08-04 |
2013-06-11 |
Manus Pharmaceuticals Canada Ltd |
composto bioativo multifuncional, composiÇço farmacÊutica, e, uso de um composto
|
DE602007008125D1
(de)
|
2006-10-31 |
2010-09-09 |
Surmodics Pharmaceuticals Inc |
Kugelförmige polymer-teilchen
|
MX2010004508A
(es)
*
|
2007-10-24 |
2010-07-02 |
Mannkind Corp |
Suministro de agentes activos.
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
CA2703338A1
(en)
|
2007-10-24 |
2009-04-30 |
Mannkind Corporation |
Method of preventing adverse effects by glp-1
|
AU2009204309B2
(en)
*
|
2008-01-04 |
2012-11-22 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
JP5856843B2
(ja)
*
|
2008-05-27 |
2016-02-10 |
アンピオ ファーマシューティカルズ,インコーポレイテッド |
ジケトピペラジンを用いた医薬組成物
|
DK2570147T3
(da)
|
2008-06-13 |
2018-01-29 |
Mannkind Corp |
Tørpulverinhalator og system til lægemiddelindgivelse
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
KR101628410B1
(ko)
|
2008-06-20 |
2016-06-08 |
맨카인드 코포레이션 |
흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
|
ES2443300T3
(es)
|
2008-08-05 |
2014-02-18 |
Mannkind Corporation |
Módulos dispensadores de polvo y conjuntos dispensadores de polvo
|
TWI532497B
(zh)
*
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
MX2011004859A
(es)
|
2008-11-07 |
2011-08-03 |
Massachusetts Inst Technology |
Lipidoides de aminoalcohol y usos de los mismos.
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
ES2531009T3
(es)
*
|
2008-12-29 |
2015-03-09 |
Mannkind Corp |
Análogos sustituidos de dicetopiperazina para su uso como agentes para la administración de fármacos
|
DK2379100T3
(en)
|
2009-01-08 |
2014-12-01 |
Mannkind Corp |
Treatment of hyperglycemia with GLP-1
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
TWI528982B
(zh)
|
2009-03-04 |
2016-04-11 |
曼凱公司 |
改良的乾粉藥物輸送系統
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
ES2751107T3
(es)
*
|
2009-06-12 |
2020-03-30 |
Mannkind Corp |
Micropartículas de dicetopiperazina con contenido de isómeros definido
|
US8734845B2
(en)
*
|
2009-06-12 |
2014-05-27 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
WO2011017554A2
(en)
|
2009-08-07 |
2011-02-10 |
Mannkind Corporation |
Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
|
CN104801215B
(zh)
*
|
2009-11-02 |
2017-11-17 |
曼康公司 |
以沉淀过程产生药物颗粒的反应器
|
CA2779613C
(en)
|
2009-11-02 |
2017-10-10 |
Mannkind Corporation |
Apparatus and method for cryogranulating a pharmaceutical composition
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
PT2506857T
(pt)
|
2009-12-01 |
2018-05-14 |
Translate Bio Inc |
Entrega de arnm para o acréscimo de proteínas e enzimas em doenças genéticas humanas
|
US9140651B2
(en)
|
2010-05-07 |
2015-09-22 |
Mannkind Corporation |
Determining percent solids in suspension using raman spectroscopy
|
RU2531455C2
(ru)
|
2010-06-21 |
2014-10-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
US9193827B2
(en)
|
2010-08-26 |
2015-11-24 |
Massachusetts Institute Of Technology |
Poly(beta-amino alcohols), their preparation, and uses thereof
|
CA2810844C
(en)
|
2010-09-07 |
2017-03-21 |
Dmi Acquisition Corp. |
Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
|
CN107854454A
(zh)
|
2010-11-09 |
2018-03-30 |
曼金德公司 |
用于治疗偏头痛的包含血清素受体激动剂和二酮哌嗪的组合物
|
SG10201802008TA
(en)
*
|
2011-02-10 |
2018-04-27 |
Mannkind Corp |
Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine
|
EP2691443B1
(en)
|
2011-03-28 |
2021-02-17 |
Massachusetts Institute of Technology |
Conjugated lipomers and uses thereof
|
MY180552A
(en)
|
2011-04-01 |
2020-12-02 |
Mannkind Corp |
Blister package for pharmaceutical cartridges
|
AU2012242768B2
(en)
|
2011-04-12 |
2017-10-12 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
EP2717861A1
(en)
*
|
2011-06-06 |
2014-04-16 |
Perosphere, Inc. |
Bioadhesive drug delivery compositions
|
TR201910686T4
(tr)
|
2011-06-08 |
2019-08-21 |
Translate Bio Inc |
Mrna iletimine yönelik lipit nanopartikül bileşimleri ve yöntemler.
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
EP2766029B1
(en)
|
2011-10-10 |
2020-03-25 |
Ampio Pharmaceuticals, Inc. |
Treatment of degenerative joint disease
|
SG10201608087WA
(en)
*
|
2011-10-10 |
2016-11-29 |
Ampio Pharmaceuticals Inc |
Implantable medical devices with increased immune tolerance, and methods for making and implanting
|
WO2013063160A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
EP4074694A1
(en)
|
2011-10-27 |
2022-10-19 |
Massachusetts Institute Of Technology |
Amino acid-, peptide- an polypeptide-lipids, isomers, compositions, an uses thereof
|
MX355446B
(es)
|
2011-10-28 |
2018-04-18 |
Ampio Pharmaceuticals Inc |
Tratamiento de rinitis.
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
US9011832B2
(en)
|
2012-02-09 |
2015-04-21 |
Novus International, Inc. |
Heteroatom containing cyclic dimers
|
WO2013142969A1
(en)
*
|
2012-03-28 |
2013-10-03 |
Jian Ping Gao |
Urethanes and ureas and processes
|
WO2013162764A1
(en)
|
2012-04-27 |
2013-10-31 |
Mannkind Corp |
Methods for the synthesis of ethylfumarates and their use as intermediates
|
US20150267192A1
(en)
|
2012-06-08 |
2015-09-24 |
Shire Human Genetic Therapies, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
MX2015000395A
(es)
|
2012-07-12 |
2015-04-10 |
Novus Int Inc |
Composiciones de matriz y capa para proteccion de bioactivos.
|
CA2878457C
(en)
|
2012-07-12 |
2021-01-19 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
WO2014028487A1
(en)
|
2012-08-13 |
2014-02-20 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
EA201591229A1
(ru)
|
2013-03-14 |
2016-01-29 |
Шир Хьюман Дженетик Терапис, Инк. |
Способы очистки матричной рнк
|
PL2968586T3
(pl)
|
2013-03-14 |
2019-01-31 |
Translate Bio, Inc. |
Kompozycje mrna cftr i związne z nimi sposoby i zastosowania
|
CA2906864A1
(en)
|
2013-03-15 |
2014-09-18 |
Ampio Pharmaceuticals, Inc. |
Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
|
BR112015023168B1
(pt)
|
2013-03-15 |
2021-08-10 |
Mannkind Corporation |
Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
|
US9315472B2
(en)
|
2013-05-01 |
2016-04-19 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
CN114848614A
(zh)
|
2013-07-18 |
2022-08-05 |
曼金德公司 |
热稳定性干粉药物组合物和方法
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
EP4276176A3
(en)
|
2013-10-22 |
2024-01-10 |
Translate Bio, Inc. |
Mrna therapy for argininosuccinate synthetase deficiency
|
EP3060258A1
(en)
|
2013-10-22 |
2016-08-31 |
Shire Human Genetic Therapies, Inc. |
Mrna therapy for phenylketonuria
|
NZ718817A
(en)
|
2013-10-22 |
2020-07-31 |
Massachusetts Inst Technology |
Lipid formulations for delivery of messenger rna
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
EA201691696A1
(ru)
|
2014-04-25 |
2017-03-31 |
Шир Хьюман Дженетик Терапис, Инк. |
Способы очистки матричной рнк
|
AU2015266764B2
(en)
|
2014-05-30 |
2019-11-07 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
CN106795142B
(zh)
|
2014-06-24 |
2022-11-04 |
川斯勒佰尔公司 |
用于递送核酸的立体化学富集组合物
|
WO2016004202A1
(en)
|
2014-07-02 |
2016-01-07 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
KR20170045274A
(ko)
|
2014-08-18 |
2017-04-26 |
앰피오 파마슈티컬스 인코퍼레이티드 |
관절 징후의 치료
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
US10500249B2
(en)
|
2014-11-17 |
2019-12-10 |
Moerae Matrix Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
BR112017019343A2
(pt)
|
2015-03-12 |
2018-05-02 |
Moerae Matrix Inc |
uso de composições contendo peptídeo inibidor de mk2 para tratamento de câncer de pulmão de células não pequenas com as mesmas
|
CN104961687B
(zh)
*
|
2015-06-03 |
2017-07-25 |
苏州维泰生物技术有限公司 |
1,2‑二嗪衍生物及其制剂、用途
|
SI3310764T1
(sl)
|
2015-06-19 |
2023-06-30 |
Massachusetts Institute Of Technology |
Z alkenilom substituirani 2,5-piperazindioni in njihova uporaba v sestavkih za dostavo sredstva subjektu ali celici
|
US11389512B2
(en)
|
2015-06-22 |
2022-07-19 |
Ampio Pharmaceuticals, Inc. |
Use of low molecular weight fractions of human serum albumin in treating diseases
|
CN114904100A
(zh)
*
|
2016-01-29 |
2022-08-16 |
曼金德公司 |
干粉吸入器
|
TW201809049A
(zh)
|
2016-03-31 |
2018-03-16 |
盧伯利索先進材料有限公司 |
生物可分解及/或生物可吸收的熱塑性聚胺甲酸酯
|
MA47603A
(fr)
|
2017-02-27 |
2020-01-01 |
Translate Bio Inc |
Nouvel arnm cftr à codons optimisés
|
WO2018213476A1
(en)
|
2017-05-16 |
2018-11-22 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
|
US10584306B2
(en)
|
2017-08-11 |
2020-03-10 |
Board Of Regents Of The University Of Oklahoma |
Surfactant microemulsions
|
WO2019071258A1
(en)
*
|
2017-10-06 |
2019-04-11 |
The Regents Of The University Of California |
SELF-ASSEMBLED MICROCAPSULES FOR ENCAPSULATION AND OPTICALLY CONTROLLED CARGO DELIVERY
|
WO2019237028A1
(en)
*
|
2018-06-07 |
2019-12-12 |
Mannkind Corporation |
Composition and method for inhalation
|
CA3108544A1
(en)
|
2018-08-24 |
2020-02-27 |
Translate Bio, Inc. |
Methods for purification of messenger rna
|